Close Menu

Biocept

Biocept's liquid biopsy diagnostic services are available to approximately 68 million people in MultiPlan's national PPO and complementary network.

The agreements with the PPOs bring the total number of Americans with covered access to Biocept's tests to about 31 million.

Pages